October 28, 2026

New Data Presented at Diabetes Technology Society Meeting Support Safe Intravenous Insulin Dosing During Labor and Delivery with EndoTool IV

Real-world analysis of 267 patients showed tight glycemic control and no severe hypoglycemia events highlighting the potential for technology-enabled glycemic...

Read More

October 27, 2026

Glooko Recognized as Finalist for the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH

Best in Class finalist in Cardiometabolic, Obesity & Diabetes category PALO ALTO, Calif., October 27, 2026 — Glooko, Inc. an enterprise software...

Read More

September 1, 2026

Glooko Expands Ambulatory Diabetes Management Offerings with GestationalCare™ Module for Diabetes in Pregnancy

Pregnancy-specific solution helps care teams prioritize risk, review fasting and post-meal patterns, engage individuals between visits, and support postpartum...

Read More

June 5, 2026

Glooko Introduces the First and Only Pump Settings EHR Integration to Bring Insulin Pump Data Directly Into Clinical Workflows

First-of-its-kind device-agnostic capability delivers critical pump configuration data into EHR flowsheets, helping clinics reduce manual documentation...

Read More

May 14, 2026

Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud

Glooko announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool IV Cloud for patient-specific insulin dosing in hospitals.

Read More

May 12, 2026

Glooko and mylife Diabetes Care Expand Diabetes Data Management Partnership

Through an expanded partnership between Glooko and mylife Diabetes Care, Glooko will serve as the primary data management provider for mylife products.

Read More